These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 11588282)
1. Rising incidence and prevalence of herpes simplex type 2 infection in a cohort of 26 year old New Zealanders. Eberhart-Phillips JE; Dickson NP; Paul C; Herbison GP; Taylor J; Cunningham AL Sex Transm Infect; 2001 Oct; 77(5):353-7. PubMed ID: 11588282 [TBL] [Abstract][Full Text] [Related]
2. Herpes simplex type 2 infection in a cohort aged 21 years. Eberhart-Phillips J; Dickson NP; Paul C; Fawcett JP; Holland D; Taylor J; Cunningham AL Sex Transm Infect; 1998 Jun; 74(3):216-8. PubMed ID: 9849560 [TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus type 2 seroepidemiology in Spain: prevalence and seroconversion rate among sexually transmitted disease clinic attendees. Varela JA; García-Corbeira P; Agüanell MV; Boceta R; Ballesteros J; Aguilar L; Vázquez-Valdés F; Dal-ré R Sex Transm Dis; 2001 Jan; 28(1):47-50. PubMed ID: 11196047 [TBL] [Abstract][Full Text] [Related]
4. Incidence and prevalence of herpes simplex virus infections in adolescent women. Fife KH; Fortenberry JD; Ofner S; Katz BP; Morrow RA; Orr DP Sex Transm Dis; 2006 Jul; 33(7):441-4. PubMed ID: 16540882 [TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of herpes simplex virus type 2 antibodies in New Zealand sexual health clinic patients. Perkins NL; Coughlan EP; Franklin RA; Reid MR; Taylor J N Z Med J; 1996 Oct; 109(1032):402-5. PubMed ID: 8937391 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. McFarland W; Gwanzura L; Bassett MT; Machekano R; Latif AS; Ley C; Parsonnet J; Burke RL; Katzenstein D J Infect Dis; 1999 Nov; 180(5):1459-65. PubMed ID: 10515804 [TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial. Gorfinkel IS; Aoki F; McNeil S; Dionne M; Shafran SD; Zickler P; Halperin S; Langley J; Bellamy A; Schulte J; Heineman T; Belshe R Int J STD AIDS; 2013 May; 24(5):345-9. PubMed ID: 23970700 [TBL] [Abstract][Full Text] [Related]
9. High prevalence of antibodies to herpes simplex virus type 2 among middle-aged women in Mexico City, Mexico: a population-based study. Lazcano-Ponce E; Smith JS; Muñoz N; Conde-Glez CJ; Juárez-Figueroa L; Cruz A; Hernández M Sex Transm Dis; 2001 May; 28(5):270-6. PubMed ID: 11354265 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors for herpes simplex virus type 2 infection among middle-age women in Brazil and the Philippines. Smith JS; Herrero R; Muñoz N; Eluf-Neto J; Ngelangel C; Bosch FX; Ashley RL Sex Transm Dis; 2001 Apr; 28(4):187-94. PubMed ID: 11318248 [TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus type 2 seropositivity and relationship status among U.S. adults age 20 to 49: a population-based analysis. Bauer GR; Khobzi N; Coleman TA BMC Infect Dis; 2010 Dec; 10():359. PubMed ID: 21176214 [TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus type 2 status at age 26 is not related to early circumcision in a birth cohort. Dickson N; van Roode T; Paul C Sex Transm Dis; 2005 Aug; 32(8):517-9. PubMed ID: 16041257 [TBL] [Abstract][Full Text] [Related]
13. Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study. Jonsson MK; Levi M; Rudén U; Wahren B Scand J Infect Dis; 2006; 38(5):357-65. PubMed ID: 16709538 [TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus type 2 cross-sectional seroprevalence and the estimated rate of neonatal infections among a cohort of rural Malawian female adolescents. Sudfeld CR; Hewett PC; Abuelezam NN; Chalasani S; Soler-Hampejsek E; Kelly CA; Mensch BS Sex Transm Infect; 2013 Nov; 89(7):561-7. PubMed ID: 23794069 [TBL] [Abstract][Full Text] [Related]
15. HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women). Schulte JM; Bellamy AR; Hook EW; Bernstein DI; Levin MJ; Leone PA; Sokol-Anderson ML; Ewell MG; Wolff PA; Heineman TC; Belshe RB South Med J; 2014 Feb; 107(2):79-84. PubMed ID: 24926671 [TBL] [Abstract][Full Text] [Related]
16. [Herpes simplex virus type 1 and 2 in Switzerland]. Laubereau B; Zwahlen M; Neuenschwander B; Heininger U; Schaad UB; Desgrandchamps D Schweiz Med Wochenschr; 2000 Feb; 130(5):143-50. PubMed ID: 10701231 [TBL] [Abstract][Full Text] [Related]
17. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada. Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690 [TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period. Woestenberg PJ; Tjhie JH; de Melker HE; van der Klis FR; van Bergen JE; van der Sande MA; van Benthem BH BMC Infect Dis; 2016 Aug; 16():364. PubMed ID: 27484304 [TBL] [Abstract][Full Text] [Related]
19. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus. Slomka MJ Commun Dis Rep CDR Rev; 1996 Mar; 6(3):R41-5. PubMed ID: 8820192 [TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1-infected persons. Ramaswamy M; Sabin C; McDonald C; Smith M; Taylor C; Geretti AM Sex Transm Dis; 2006 Feb; 33(2):96-101. PubMed ID: 16432480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]